Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Biden selects cardiologist who served under Obama to run FDA | Vaccine-related heart damage in Taiwan
Monday, November 15, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Biden expected to choose cardiologist who served under Obama as next FDA commissioner

Robert Califf, MD, is a practicing cardiologist and professor of cardiology at the Duke University School of Medicine. 

READ MORE >
 U.S. Senate has confirmed cardiologist Robert Califf as next FDA commissioner. 
Share on Twitter Share on Facebook Share on Linkedin

Biden expected to choose cardiologist who served under Obama as next FDA commissioner

Share on Twitter Share on Facebook Share on Linkedin
 U.S. Senate has confirmed cardiologist Robert Califf as next FDA commissioner. 
Robert Califf, MD, is a practicing cardiologist and professor of cardiology at the Duke University School of Medicine. 
READ MORE >

Taiwan pauses second doses of Pfizer-BioNTech COVID-19 vaccine for older children due to myocarditis

A final decision is expected in approximately two weeks. 

READ MORE >
vaccine
Share on Twitter Share on Facebook Share on Linkedin

Taiwan pauses second doses of Pfizer-BioNTech COVID-19 vaccine for older children due to myocarditis

Share on Twitter Share on Facebook Share on Linkedin
vaccine
A final decision is expected in approximately two weeks. 
READ MORE >

New risk calculator detects TEER patients who may need to be readmitted for HF

Once the tool's performance is properly validated, it could help clinicians deliver better patient care and result in significant cost savings for health systems.

READ MORE >
calculation
Share on Twitter Share on Facebook Share on Linkedin

New risk calculator detects TEER patients who may need to be readmitted for HF

Share on Twitter Share on Facebook Share on Linkedin
calculation
Once the tool's performance is properly validated, it could help clinicians deliver better patient care and result in significant cost savings for health systems.
READ MORE >

Eating the right kind of fats can reduce a person's stroke risk

The new findings are from research to be presented at AHA Scientific Sessions 2021.

READ MORE >
Intermittent fasting may improve heart health for some breast cancer survivors
Share on Twitter Share on Facebook Share on Linkedin

Eating the right kind of fats can reduce a person's stroke risk

Share on Twitter Share on Facebook Share on Linkedin
Intermittent fasting may improve heart health for some breast cancer survivors
The new findings are from research to be presented at AHA Scientific Sessions 2021.
READ MORE >

New research details how drug and alcohol use increases a person's AFib risk

The findings, to be presented at AHA Scientific Sessions 2021, focused on methamphetamines, opiates, cocaine, cannabis and alcohol. 

READ MORE >
heartburn.jpg
Share on Twitter Share on Facebook Share on Linkedin

New research details how drug and alcohol use increases a person's AFib risk

Share on Twitter Share on Facebook Share on Linkedin
heartburn.jpg
The findings, to be presented at AHA Scientific Sessions 2021, focused on methamphetamines, opiates, cocaine, cannabis and alcohol. 
READ MORE >

Featured Articles

Texas cardiologist named in lawsuit says he will not be 'silenced by corporate bullies’

The interventional cardiologist allegedly 'entered into a conspiracy' with other area providers to interfere with recruiting efforts. He has now responded to the allegations, however, and is not backing down. 

READ MORE >
A gavel and a stethoscope
Share on Twitter Share on Facebook Share on Linkedin

Texas cardiologist named in lawsuit says he will not be 'silenced by corporate bullies’

Share on Twitter Share on Facebook Share on Linkedin
A gavel and a stethoscope
The interventional cardiologist allegedly 'entered into a conspiracy' with other area providers to interfere with recruiting efforts. He has now responded to the allegations, however, and is not backing down. 
READ MORE >

We may finally know why type 2 diabetes is associated with vascular damage

New research published in Diabetes provides some potential answers to a big question. 

READ MORE >
Elderly patient doctor. Despite an expanded indication from the FDA and lower prices, patient access to these cholesterol-lowering medications remains a significant issue.
Share on Twitter Share on Facebook Share on Linkedin

We may finally know why type 2 diabetes is associated with vascular damage

Share on Twitter Share on Facebook Share on Linkedin
Elderly patient doctor. Despite an expanded indication from the FDA and lower prices, patient access to these cholesterol-lowering medications remains a significant issue.
New research published in Diabetes provides some potential answers to a big question. 
READ MORE >

How the presence of AFib can impact TAVR, SAVR outcomes

AVR patients may require a longer hospitalization if they present with pre-existing or new-onset AFib.

READ MORE >
HF-related mortality among older adults improved from 1999 to 2012, but then decreased considerably over the next several years. Researchers explored the latest data at length, sharing their findings in JACC: Heart Failure.
Share on Twitter Share on Facebook Share on Linkedin

How the presence of AFib can impact TAVR, SAVR outcomes

Share on Twitter Share on Facebook Share on Linkedin
HF-related mortality among older adults improved from 1999 to 2012, but then decreased considerably over the next several years. Researchers explored the latest data at length, sharing their findings in JACC: Heart Failure.
AVR patients may require a longer hospitalization if they present with pre-existing or new-onset AFib.
READ MORE >

Mental stress–induced myocardial ischemia elevates risk of CV events

The study's authors wrote that additional research is warranted to assess whether testing for mental stress–induced ischemia provides value.

READ MORE >
New research out of the Yale School of Public Health suggests that patients taking beta-blockers or antiplatelet medications may want to be extra careful in warmer weather.
Share on Twitter Share on Facebook Share on Linkedin

Mental stress–induced myocardial ischemia elevates risk of CV events

Share on Twitter Share on Facebook Share on Linkedin
New research out of the Yale School of Public Health suggests that patients taking beta-blockers or antiplatelet medications may want to be extra careful in warmer weather.
The study's authors wrote that additional research is warranted to assess whether testing for mental stress–induced ischemia provides value.
READ MORE >

In Other News

130-year-old Johnson & Johnson will split into two public companies

J&J's consumer business—responsible for Tylenol, Band-Aid and more household names—will separate from its pharmaceutical and medical device division.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

130-year-old Johnson & Johnson will split into two public companies

Share on Twitter Share on Facebook Share on Linkedin
J&J's consumer business—responsible for Tylenol, Band-Aid and more household names—will separate from its pharmaceutical and medical device division.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme